Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis
Niamatali, C.; Fallon, S.D.; Egan, E.L.
Irish Medical Journal 77(9): 276-277
1984
ISSN/ISBN: 0332-3102 PMID: 6090342 Document Number: 235205
Document emailed within 1 workday
Related Documents
Burris, H.; Hesketh, P.; Cohn, J.; Moriconi, W.; Ryan, T.; Friedman, C.; Fitts, D. 1996: Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy Cancer Journal from Scientific American 2(2): 85-90Nukariya, N.; Nakarai, I.; Kobayashi, H.; Koizumi, W.; Komatsu, H.; Uchiyama, T.; Yamaguchi, T.; Taira, O.; Minato, K.; Futatsugi, K. 1995: A comparative study of the effect of granisetron and a combination of granisetron plus steroids on cancer chemotherapy induced emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1821-1829
Barisano, A.; Mehl, B.; Bradbury, K. 1992: Serotonin antagonists: treatment of chemotherapy-induced emesis Mount Sinai Journal of Medicine new York 59(5): 433-437
Fisher, R.D.; Rentschler, R.E.; Nelson, J.C.; Godfrey, T.E.; Wilbur, D.W. 1982: Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in man Cancer Treatment Reports 66(1): 25-29
Chiou, T.J.; Wei, C.H.; Hsieh, R.K.; Fan, F.S.; Liu, J.H.; Chen, P.M. 1995: Comparison of intravenous granisetron with metoclopramide in the treatment of chemotherapy-induced emesis Zhonghua Yi Xue Za Zhi 56(1): 23-30
Perez, E.A.; Gandara, D.R. 1994: The clinical role of granisetron (Kytril) in the prevention of chemotherapy-induced emesis Seminars in Oncology 21(3 Suppl. 5): 15-21
Ettinger, D.S. 1995: Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis Seminars in Oncology 22(4 Suppl. 10): 6-18
van Groeningen, C.J.; Gall, H.E.; Simons, K.A.; van Loenen, A.C.; Knobf, M.K.; Nauta, J.; Vermorken, J.B.; Pinedo, H.M. 1989: Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis Netherlands Journal of Medicine 35(5-6): 283-294
Hesketh, P. 1995: Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy Seminars in Oncology 22(4 Suppl 10): 19-23
Feng, F.; Zhang, P.; He, Y.; Li, Y.; Zhou, M.; Chen, G.; Li, L. 2002: Clinical comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea and anorexia Chinese Medical Sciences Journal 17(3): 168-172
Voldeng, A.N. 1976: Management of the acutely poisoned patient. Part II. Alternatives to induced emesis Journal of the Arkansas Medical Society 72(9): 368-369
Miyazaki, Y.; Miyazaki, S.; Fujita, S.; Hirose, H.; Sugimoto, S.; Michiura, T.; Yamabe, K.; Nagaoka, M. 2014: A case of advanced rectal cancer with irinotecan (CPT-11)-induced delayed emesis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1835-1837
Sampi, K. 1987: Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 951-955
Van Gijn, J. 2000: Diagnostic image (17). Acute dystonia induced by prochlorperazine Nederlands Tijdschrift Voor Geneeskunde 144(52): 2496
George, M.; Pejovic, M.H.; Thuaire, M.; Kramar, A.; Wolff, J.P. 1983: Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin Biomedicine and PharmacoTherapy 37(1): 24-27
Takatsuki, K.; Kado, T.; Satouchi, M.; Nakajima, T.; Nagai, K.; Ohsugi, F.; Yanagida, E.; Minegaki, A. 1998: Psychiatric studies of chemotherapy and chemotherapy-induced nausea and vomiting of patients with lung or thymic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(3): 403-408
Rosino, A.; Ballester, I.; Tudela, J.án.; González-Billalabeitia, E. 2018: Chemotherapy in metastatic castration resistant prostate cancer Archivos Espanoles de Urologia 71(8): 676-684
Tabona, M.V. 1990: An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy European Journal of Cancer 26(Suppl 1): S37-S44
Chan, S. 1997: Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy Oncology 11(8 Suppl 8: 19-24
Vaille, C.; Rozé, C.; de La Tour, J.; Souchard, M.; Debray, C. 1978: Action of chlorpromazine, prochlorperazine, metoclopramide and imipramine on central vagal stimulation of pancreatic secretion induced by 2-deoxy-D-glucose Annales Pharmaceutiques Francaises 36(3-4): 149-155